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ABSTRACT
In this paper, we investigate how information visualization
techniques can be leveraged to increase patient compre-
hension of personal medication schemes in order to make
it easier for them to explore, explain and understand
drug information. Using computer vision techniques, our
solution is able to recognize medication boxes, or so-called
pharmaceutical packages, which are laid on an ordinary
table. A projector visualizes drug information such as inter-
actions, adverse drug reactions, intolerances and the dosage
regimen around corresponding boxes. Five prototypes are
designed and evaluated following a user-centered, rapid-
prototyping methodology. Test participants in our study
included both general practitioners (GPs) and patients.
Results are promising and clearly indicate that information
visualization techniques are an effective means to explore
and understand drug information. Even if this system
was originally envisaged to be used as a means to improve
‘therapy dialogue’ between GPs and their patients during
consultations, our results show that both GPs and patients
think it would be highly beneficial if patients were able to
use the system at home.
CCS Concepts
•Human-centered computing → Information visual-
ization; Empirical studies in HCI;
Keywords
Information visualization; personal medication scheme
1. INTRODUCTION
General practitioners (GPs) have too much work [14].
Moreover, the resulting lack of time influences doctor-
patient relationships and compromises patient-centered care
[14]. We learned in previous meetings with GPs that
they like patients who arrive prepared. However, health
information is complex and is not always straightforward
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to explore or communicate. The degree to which people
have the capacity to obtain, process, and understand health
information is called health literacy. We argue that informa-
tion visualization technology can help to improve ‘therapy
dialogue’ and thus make it easier for a GP to explain
complex health information. More specifically, we wanted to
learn if we can augment the practitioner’s office by installing
a system that is able to visualize health information on, for
example, the table that is usually between the GP and the
patient. The GP can then use these visualizations to discuss
health information more efficiently with a patient.
Discussion groups were organized as part of a larger
project which examines the potential added value of un-
locking health data for patients and looks for solutions
to bring down potential barriers in the patient-caregiver
interaction. In each group patients elicited questions around
medication. “Why do I have to take this medication?”,
“Which are my adverse reactions?”, and “Are there any
alternatives?” are examples of commonly asked questions.
Drug information can be cumbersome after all: dosage
regimen, adverse drug events, and interactions are only
a few examples of information patients should understand
concerning medication intake. In this paper we propose an
information visualization technology approach as a potential
solution to address this problem. Hence, the aim of this
study is to determine if information visualization technology
has the potential to increase patient comprehension of their
personal medication schemes.
Based on lessons learned from related work and interviews
with patients during the discussion groups, we designed
a proof-of-concept that assists both patients and GPs to
explore and discuss medication related information. More
specifically, using computer vision techniques our solution
recognizes medication boxes1 which are laid on an ordinary
table. A projector visualizes drug information such as
interactions, adverse drug reactions, intolerances and the
dosage regimen around corresponding boxes as can be seen
in Figure 1. The choice for medication boxes is made because
patients are able to buy medication without prescription or
even in a supermarket. This means that electronic medical
records are not always up to date. It is thus hard to maintain
an overview of the medication a patient is currently taking
and expose possible unwanted interactions. To tackle this
issue, GPs can ask patients to collect all their medication
boxes and bring them to the office. Without the boxes
patients would need to write down all medication they take
1Refers to the actual (paper) box that contains blister packs
or bottles; also called pharmaceutical packages
Figure 1: (left) Schematic side view of the set-up.
(right) Real-life set-up of the final design with four
real medication boxes.
and this is error prone due to hard spelling and variations
of medication. Moreover, this set-up also supports patients
who already take their medication to a GP.
2. LITERATURE STUDY
This section starts with an overview of research opportu-
nities, discusses visualizations dealing with drug information
and concludes with a discussion on tabletop affordances.
2.1 Information Visualizations Opportunities
Caban and Gotz [9] stated that “[t]he large volume of
clinical data now being captured for each patient poses many
challenges to clinicians trying to combine data from different
disparate systems and make sense of the patient’s condition
within the context of the patient’s medical history” [9]. A
potential approach to deal with these large amounts of data
are information visualizations. Health information visual-
izations can indeed provide opportunities to improve health
care [21]. Hence, Shneiderman, Plaisant and Hesse [21]
list three overlapping domains of what they call ‘Health
2.0’: first, visualizations should use personal information
such as personal medication schemes; second, visualizations
should extract data from an electronic medical record
(EMR) such as the reason for taking a drug; and finally
visualizations should use public health information such as
a public database to look up possible adverse reactions.
More specifically from an HCI approach, Nunes et al. [17]
consider existing collaborations in self-care as one of the
opportunities to improve the quality of care. Furthermore,
visualizing chronic condition data emerged as one of their
six design-related tensions from their analysis.
Rxplore [15] is an example of a visual tool that helps
GPs assess medication side-effects. Even though Rxplore
only uses simple bar charts, it is able to retrieve in-
formation on multiple medications simultaneously. The
second reported strength is the immediately interpretable
visual representation of medical data. Furthermore, we can
learn from Siek et al. [22] that there is a contradiction
between caregivers, who prefer the overview of an entire
day, and older adults who primarily want to see when their
next medication was scheduled [22]. However, from their
first study, we also learn that their participants liked the
visual qualities of a clock visualization and kitchen counter
prototypes [22]. Another valuable research project is the
Visualizing Health project that contains 54 examples of
tested visualizations. In comparative tests between tabular
and non-tabular formats, graph ‘Tables of side effect risks
with icons’2 helped viewers best to understand how different
side effect vary in their risk and severity.
2.2 Tabletop Affordances
We will combine lessons learned from previous medication
visualization research with tabletop affordances to increase
patients’ comprehension of personal medication schemes.
Piper and Hollan [19] have shown that a large horizontal
touch-screen suits the needs of older patients and that it
can facilitate the doctor–patient interview process. They
conclude that older adults like to have a shared view
of electronic medical records and that “a large multiuser,
multitouch display may be an effective device for presenting
such information to older patients.” [19]. This is in line
with Asan et al. [4] who have found that active information
sharing seems to engage patients and that training and
design can help doctors to engage patients in communi-
cation. The optimal positioning of the computer screen
has the potential of improving interpersonal communication
between caregivers and patients [2]. However, in the health
domain tabletop devices are mostly used to train physi-
cians [24] or help patients rehabilitate [3]. Nevertheless,
in the domain of learning analytics, tabletops have been
extensively researched. Dillenbourg and Evans [13] provided
an extensive overview of tabletop research in the learning
analytics domain. However, these concepts can also be
applied in the health domain as an expert user can be the
teacher or the GP and the layman can be a student as well as
a patient. In our work we apply their suggested affordances,
such as hands-on activities, and design recommendations,
such as the use of objects by projecting the proposed
visualizations around medication boxes.
3. ITERATIVE DESIGN PROCESS
This section starts with a description of the chosen
approach followed by a discussion of the initial design.
Changes to the design are documented together with the
motivation for each change in the subsequent subsections.
3.1 User-centered, Rapid-prototyping Design
In order to augment the GP’s office with projected visu-
alizations, a user-centered, rapid-prototyping methodology
was applied to gradually improve the initial design of the
visualizations. This approach has proven to be successful
in other information visualization studies in the pervasive
health domain [12, 17]. In line with this methodology, our
design evolved quickly. After every evaluation, qualitative
feedback was addressed in the next prototype, which was
then again evaluated. One low and four high fidelity
prototypes were designed and evaluated.
Patients in general, and more specifically adults who need
to take medication, were selected as the target audience.
Participants were recruited through mail or a phone call,
in which we shortly explained the goal of this research
and asked if they would want to participate. Participation
was voluntary and not compensated. Furthermore, they
2See http://www.vizhealth.org/gallery/assets/89/ for an
example on how to represent side effects severity and risk.
Figure 2: Part of the initial low fidelity prototype.
could only participate once. Throughout individual face-to-
face interviews, the concurrent Think-Aloud Protocol [16]
was applied to let participants explain what they think
when seeing the visualizations. In this way it can be
tested whether participants understand the message the
visualization tries to convey.
3.2 Low Fidelity Iteration
The first prototype, of which a small segment is shown
in Figure 2, was designed on paper. Nevertheless, this
allowed us to test the initial design where patients put
their medication boxes on the table between them and
a GP. Once the medication is put on the table, the
system hypothetically recognized the boxes and visualized
concentric circles surrounding the corresponding medication
boxes. The inner circle visualizes the dosage regimen
(Figure 2A) and is visualized as a 24-hour clock. The
colored segments indicate between which hours patients
should take medication. The outer circles are subdivided
into three categories: 1) lifetime medication, visualized with
one red circle; 2) time-independent or if-needed medication,
visualized with one green circle; and 3) medication that
should be taken during a certain period visualized using
one or more (for each month) orange concentric circles
(Figure 2B). An auxiliary text in the upper part of each
circle explains which month each circle represents. GPs
can choose which medication related information they want
to discuss and can put a paper card on the table for
each adverse reaction (Figure 2C), episode (Figure 2D),
and allergy/intolerance (Figure 2E) of the patient. A
network is drawn to link common elements after the boxes
are recognized. Green arrows for reasons and/or linked
episodes, blue arrows for adverse reactions and red arrows
for interactions between medication or between medication
and allergies.
The initial design was tested with five participants. Since
the low fidelity prototype was made on paper, a researcher
acted as the computer that recognizes the boxes and draws
the projected interface. Furthermore, six medication boxes,
that were not necessarily familiar to the participant, were
provided by the researcher so the interface could be drawn
in advance in order to save time. Hence, the low fidelity
prototype was only tested with these boxes. Nevertheless,
these six boxes were sufficient to test the initial design. The
evaluation protocol as explained in Section 3.1 was applied
when the participant interacted with the system.
Only two out of five participants correctly linked the
green color to episodes and blue colors to adverse reactions.
Moreover, participants linked these colors to the colors used
in the circles surrounding the boxes. Another confusion for
three participants was the colors used to separate between
lifetime and if-needed medication. Participants perceived a
green color as safe to take, whereas a red colors indicates
danger. However, in the initial design medication that
can be taken if needed is shown in green and a lifetime
medication red. Finally, two participants rightfully stressed
out the fact that there are too many possible adverse
reactions for GPs to put cards on the table. Nonetheless,
the initial design was a good start. However, these remarks
needed to be addressed in the next prototype.
3.3 First High Fidelity Iteration
The high fidelity prototype was designed based on the
lessons learned as described in the previous section. The
goal of this iteration was again to evaluate the concept
and discover possible usability issues. Furthermore, it
was tested whether the three changes implemented were
successful: 1) Only one color is used for the arrows as the
direction indicate the reason for taking a drug (towards the
medication box, (Figure 3A) and possible adverse reactions
(towards the adverse reaction, (Figure 3B). 2) Episodes and
adverse reactions are no longer individual cards, but are a
computer generated list on the left side of the projection
area. 3) If-needed medication is drawn with only the dosage
regimen circle (Figure 3C) and lifetime medication is drawn
with one green circle, which is the opposite color of the paper
prototype. After all, the system did not want to give the
impression a medication patients have to take their entire life
is ‘bad’. Other medication was still visualized using orange
circles as shown in Figure 3D.
This updated design was also tested with five participants
using the same evaluation protocol. All participants liked
the overview the system provides, the opportunity to move
boxes around to create their personal view, and the clear
overview of possible adverse reactions. However, three out
of five participants did not immediately understand the
outer circles represented months. It became clear that using
full circles to represent months is not optimal since each
day starts at a slightly different angle for a 30- or a 31-
day month. Three out of five participants explained they
would understand the design better with more auxiliary
text. Two out of five participants were confused with the
start of each arrow. Since each arrow started from the outer
circle, two participants thought risks are only relevant at
that particular moment the arrow originated. Furthermore,
arrows were drawn without collision detection. Hence, two
participants mentioned the visualization was too crowded;
especially when medication with numerous potential adverse
reactions was put on the table. Although this prototype
was an improvement over the initial design, previously
mentioned usability remarks needed to be addressed in an
additional prototype.
3.4 Public Iteration
The third prototype was based on the lessons learned
in the first high fidelity prototype. We wanted to test
whether new changes were successful: 1) The concentric
Figure 3: A visual example of how circles were
projected surrounding a medication box in the high
fidelity iteration.
circles as shown in Figure 3 were altered to large concentric
arc segments as shown in Figure 4A. In this visualization,
each day is an arc of 11.4 degrees and starts at the same
angle. There was thus still room for auxiliary text such
as the name of each month. For example, November is
an arc of 341 degrees and December of 352 degrees, see
Figure 4A for a visual example. 2) Auxiliary text was
added to differentiate between episodes, adverse reactions
and personal data. 3) Lines were drawn from the center of
each circle to avoid that users link adverse reactions to a
time period as shown in Figure 4B. 4) The table colored red
to warn users of a potentially dangerous situation when an
interaction is detected.
We had the opportunity to test this third prototype
as a fully functional proof-of-concept during the national
company discovery day at the Computer Science department
in Leuven. We provided ten medication boxes that could be
used during the demo. The prototype was explained by
a researcher in approximately one minute. In total 220
persons interacted with the demo and stayed on average
almost 5 minutes (288s, σ = 143s). Participants expressed
their interest by asking when they could actually start
using the system in a personal setting. Even though
not scientifically relevant, people were interested if there
were plans to commercialize the system, which stresses the
genuine interest of people and the need for such a system.
Three users, who indicated they have to take medication
on a regular basis, wanted to be informed of cheaper
alternatives. Four care providers indicated it would be
useful to visualize the probability of adverse reactions.
Unfortunately, some users experienced problems following
the lines. Especially when a medication box was placed on
the right side, which is the opposite side of the episodes
and adverse reaction. Therefore, lines could be long and
hard to follow around several other medication boxes. The
changes made in this prototype performed well. Only minor
changes needed to be implemented in the next iteration.
Nonetheless, feedback from GPs needed to be gathered
before the visualizations could be finalized.
3.5 Medical Iteration
This iteration served to gather extensive feedback from
GPs. We primarily wanted to test the medical relevance
and learn if the visualizations are clear to GPs as well.
As with the previous iterations, changes as a result of user
Figure 4: Updated visual example of how circles
were shown in the public iteration.
feedback were implemented in a fourth prototype and tested:
1) Using a five category frequency scale3 adverse reaction
probability can be classified as ordinal data. To help the
user judge on this information color saturation was used.
2) Since the color scheme from the second prototype was
not sufficient anymore a new color scheme was mapped out.
Negative interactions were colored red as the system was
tested in the Western culture. To maintain consistency,
adverse reactions and episodes were drawn in analogous
colors: purple for adverse reactions and blue for episodes.
In addition, labels were colored similarly to aid user’s short
term memory to quickly recognize the meaning of each
color. To visualize time information complementary colors
were used: the dosage regimen in yellow, the schedule in
orange and lifetime medication in green. 3) Moreover, the
rectangles were projected in the middle of the visualization
instead of the left side. This way, lines were shorter and
easier to follow. These colors are also used in the final design
as is shown in Figure 5.
The system was evaluated for perceived usefulness using
printouts and examples shown on a computer screen. Two
expert GPs evaluated the system using the same evaluation
protocol as in the first two iterations. Furthermore, they
were asked specific questions such as “what kind of medi-
cation questions patients ask the most” and “what do you
experience is hardest to explain?”. As expected, answers
were in line with questions asked by patients.
The design was well received. The major concern raised
was time pressure during a consultation. Therefore, the GPs
argued the system should be made accessible to patients
before they visit. This way questions the patient might
have can be solved autonomously using the system. Unclear
answers can then be discussed afterwards during a face-to-
face meeting using the system. It must also be possible
for GPs to configure the level of adverse reactions shown
due to the nocebo phenomenon [6]. In contrast, patients
expressed they liked the fact that they have the same
overview as their GP. Concerns were also raised that adverse
reactions are rarely registered. Furthermore, the source of
each data element should be unambiguous. Finally, it was
3The Council of International Organizations of Medical
Sciences divided the frequency of adverse drug reactions in
five categories: 1) very common (>= 1/10), 2) common (>
= 1/100 and < 1/10), 3) uncommon (>= 1/1000 and <
1/100), 4) rare (>= 1/10000 and < 1/1000), and 5) very
rare (< 1/10000).
brought to the researchers attention that food can also cause
interactions [10]. The feedback will be incorporated into the
final design.
3.6 Final Design
The final design is shown in Figure 5 and is the result
of all lessons learned thanks to the user-centered, rapid-
prototyping approach. One minor visual update is added to
the previous iteration. The source of data is made explicit
as this was a requirement of the GPs. Data originating
from the EMR is displayed on the left (Figure 5A+C), data
from other trusted sources, such as adverse reactions that are
retrieved from a validated database, remain in the middle
(Figure 5B) and patient added data such as food could be
visualized on the right.
4. TECHNICAL DETAILS
The system to recognize the medication boxes is im-
plemented using JavaCV4. To recognize the medication
boxes a Logitech c270 with a 1280x960 resolution and a
60 degrees field of view was used in the first high fidelity
prototype and a Logitech c930e camera with a 1920x1080
resolution and a 90 degrees field of view in the subsequent
iterations. Furthermore, a NEC MT1055 projector with
a 1024x768 resolution was used to project the first high
fidelity prototype on a 120cm x 80cm x 75cm table. In
the subsequent prototypes an Epson EH-TW5000 with a
1920x1080 resolution projected the visualizations. The
visualization itself, which is projected around medication
boxes, is implemented using the D3js [7] library. Episodes,
allergies and personal data are extracted from an EMR using
simple SQL queries, while adverse reactions are manually
extracted from medication leaflets. However, during the user
tests a modified patient record was used for anonymity.
In order to improve the implementation, an additional
technology iteration was organized after the second iteration
with five participants to discover potential bugs. In this
iteration, a Samsung UE60F6100 TV is used instead of a
projector. We wanted to test if hanging the camera closer
to the table, could improve the accuracy of the detection
and thus tighten the virtual bounding boxes surrounding
each medication package. However, the TV performed worse
than expected since light emitted by the TV darkens the top
of the medication boxes the camera needs to detect. On the
other hand, with a black background, reflections from the
lights in the ceiling were an issue. Furthermore, due to the
relatively low resolution of the TV for this large working
environment, text was unreadable. Finally, the field of view
limited the height of the camera.
5. FINAL EVALUATION
The goal of the final evaluation was to determine if
information visualization techniques are an effective means
to help increase patients’ comprehension of their personal
medication schemes. Furthermore, the evaluation also
served to assess the perceived usefulness and usability of
the last design.
5.1 Evaluation Protocol
The final design was evaluated with 25 participants
(16 males and 9 females) who were on average 32 (σ = 16.3)
4https://github.com/bytedeco/javacv
years old; their age ranging from 18 to 75 years. Partic-
ipants were recruited in a similar manner as described in
Section 3.1. Eleven participants needed to take medication
on a daily basis, while only one participant visited his GP
every month. Participants were asked to fill in a short
questionnaire measuring relevance and interest. Thereafter
they were asked to perform a list of tasks (which will be
discussed in further detail in Section 5.2) on a medication
scheme with four different medications. These tasks were
reviewed beforehand by a GP to test medical relevance of
each task. Furthermore, time-to-task and the number of
errors was measured. As with the evaluations in the iterative
design process, participants were asked to think aloud [16].
Moreover, they were not recorded. The evaluation ended
with six questions to measure if the visualizations were
clear (green and blue box plots in Figure 6), five perceived
usefulness [18] questions (purple box plots in Figure 6),
and a System Usability Score (SUS) [8] questionnaire. The
interactive version installed at the department was shown to
14 participants, whereas 11 participants were shown a static
version as it was not always possible to install the entire
system at their homes.
5.2 Usability and Tasks
The system scored an average SUS score [8] of 79.5
(σ = 10). This high usability score reflects on the timings
participants needed to perform each task and on the low
number of mistakes made. The first task where participants
were asked “When do you have to take drug 1?” took on
average 16s (σ = 9.4, 1 error). Tasks where they only needed
to follow a line were completed with an average time less
than 10s: “Why do you have to take drug 2?” (9s ± 11.7s, 1
error), “Which are all the possible adverse-reactions of drug
1?” (7s ± 4.8s, 0 errors), “Can you currently drive a car?”
(9.8s ± 12.1s, 3 errors), “Can you still breastfeed your child?”
(3.2s ± 3.3s, 0 errors). Other tasks were completed in less
than 15s: “What is the probability that you will catch a dry
throat?” (12.8s ± 10.8s, 0 errors), “Can you combine drug
1 and drug 3?” (10.8s ± 7.7s, 2 errors), “At what times do
you have to take drug 2?” (10.1s ± 11.3s, 1 error).
5.3 Likert Scale Questionnaires
As illustrated in Figure 6, answers to Likert scale ques-
tions scored consistently. When participants were asked
if our system increased their comprehension of medication
schemes all but one participant (neutral) agreed; 64% par-
ticipants even strongly agreed. Furthermore, participants
agreed that the design can create medication awareness
and as well as that there is a need for a system to help
explore drug information. The six blue box plots in Figure 6
concern dialogue-related questions. Participants strongly
agreed our design can indeed help GPs explain personal
medication schemes. On top of that, they agreed they would
actually like to use the system when they discuss medication
with their GP. On the other hand, only 76% participants
agreed the system can help them to explain their medication.
Although the system was originally envisaged to be used
as a means to improve the dialogue between GPs and
their patients during consultations, 84% (the other 16%
was neutral) indicated they do not need a GP to use the
system. In fact, 80% participants preferred to use the
system at home. Whereas only three participants preferred
the pharmacy, one participant preferred the GP’s practice
Figure 5: Overview of the final design. Blue rectangles and lines visualize the reasons why a patient has to
take each particular medication (A). The lower right circle does not have an EMR registered reason and can
be a drug the patient bought without prescription. Purple rectangles and lines visualize possible adverse
reactions, while a higher saturation indicates a higher frequency of occurrence (B). In the lower left corner
personal data such as allergies and age are drawn to visualize interactions using red lines (C). In this figure,
the medication images are added afterwards to illustrate how the visualization looks when projected around
the boxes, in reality these are real medication boxes as is also visible in Figure 1.
and one participant wanted to use the system at all three
locations. Finally, the four purple box plots in Figure 6
show the distribution on the perceived usefulness questions.
Participants agreed this was the right kind of tool to explore
drug info and that the system provided a useful source of
feedback. This approach could help to prevent medical
mistakes according to 84% (12% neutral and 4% disagree).
Finally, the details were at the right level as reported by
84% (8% neutral, 8% disagree) of participants.
6. DISCUSSION
Overall, the results of this study indicate the system
can indeed help to increase patient comprehension of their
personal medication schemes. Moreover, even if this system
was originally envisaged to be used as a means to improve
‘therapy dialogue’ results show that both GPs and patients
think it would be highly beneficial if patients were able to
use the system at home.
6.1 Iterations
Changes made to the initial design, as described in
Section 3, improved functionality and general usability.
In all iterations, participants only raised usability issues
Figure 6: Answers ranging from 1 (strongly
disagree) to 5 (strongly agree). The green box
is related to our research question, blue boxes
indicate dialogue related questions and purple boxes
visualize perceived usefulness questions.
and additional requirements, none disagreed with decisions
made. Suggestions raised during the different iterations
were incorporated. However, patients and GPs disagreed
on the level of detail shown. Patients mentioned they
like the fact that they have the same overview, yet GPs
expressed the necessity of being able to configure the level
of details shown to the patient for health reasons, such as
the nocebo phenomenon [6]. This is a complex issue with
implications on how the patient can understand and manage
their condition [17]. As our design requires uptake from GPs
first, we currently follow the GPs’ view and implemented
programmatic flags that should be configured before the
start of the system. This enables GPs to choose the level
of details, such as the frequency of adverse reactions, shown
to the patient. Furthermore, this does not interfere with
Shneiderman’s mantra [20] as all information that can be
disclosed is still visualized in an overview.
6.2 Final Evaluation
The first task, where participants were asked to indicate
on which days they had to take a particular medication,
clearly took the longest time with an average duration of 16s.
This may be due to the fact that this was the first task. On
the other hand, this was also a harder task since participants
needed to figure out that each orange circle represented
one month. An initial training task would have enabled
us to provide a clearer answer why this task took most
time. The only qualitative feedback participants provided
during this task was that is was not always immediately
clear which was the current day. Although all other tasks
were completed in less than 15s, some participants initially
tried to form an answer based on adverse reactions. For
example, when participants were asked if they could combine
two medications, nine participants first checked the possible
adverse reactions. However, in the end only two participants
made a mistake by drawing their conclusion on adverse
reactions and not on the visualization. We noticed a
similar pattern when participants were asked if they could
still drive a car; six participants initially looked at the
adverse reactions. Other situations where it occasionally
took participants more than 30s to complete a task are
because of older participants who needed their reading
glasses first. Nevertheless, timings are shorter compared to
the traditional way of opening the leaflet, find your own
language, and find the right section. When we asked five
participants to look up the adverse reactions in the leaflet it
took them on average more than half a minute (38s ± 8s). A
technical solution can provide a faster solution, as is evident
from our results.
The SUS score of 79.5 indicates the usability can be
considered between ‘good’ and ‘excellent’ [5]. Yet, it could
potentially be higher. The first question which asked if
participants think they would use the system frequently
scored on average only 3.92 (σ = 0.9) out of the five
possible points. However, qualitative feedback learned us
that users would only use the system when they actually
have medication questions.
6.3 Tendency to Consultation Preparation
A common trend, that was already noticed during the
iterative design process, is that participants were genuinely
surprised by how many questions could be answered without
the assistance of a GP. This reflects in the results in
the final evaluation where 80% of participants indicated
they would like the system at home and do not need
help of a GP. On top of that, GPs indicated they do
not have enough time for an in depth discussion with all
patients. Moreover, using our design, participants were
able to answer the questions as described in Section 5.2.
Hence, thanks to this study, we learned both GPs and
participants preferred to use our visualization individually.
We, therefore, argue for a medication system included in
personal health record systems that can be used to explore
medication questions before a consultation. The proposed
system can subsequently be used to explore and discuss non-
resolved questions with a GP. However, our visualizations
were not designed nor evaluated to be used on an everyday
basis and it is not well known what it means to be in need
of medication management support in everyday life [11].
Furthermore, people have divergent ways they want to
integrate disease management into their homes [1]. It
should thus be researched further if this individually gained
medication comprehension actually leads to empowerment,
or to confusion and anxiety [23].
6.4 Limitations
Four limitations of the present study should be ac-
knowledged. First, although it is designed to be an
interactive system, detection of medication boxes did only
occur in near real-time. Approximately one second per
box is needed to detect a box on the table. However,
as this work primarily focuses on the perceived usefulness
of our proof-of-concept, we did not measure efficiency
parameters, such as response time. This might have
influenced our results since participants could be reluctant to
move medication boxes around for better readability. This is
presumably why we could not detect any differences between
the static and interactive version in the final evaluation.
Nevertheless, participants still perceived the system as
useful. Secondly, since this work describes a proof-of-
concept design, it is not evaluated ‘in the wild’. Nonetheless,
with this methodology we were able to demonstrate the
perceived usefulness. Third, the system was not directly
compared to other systems. The setup of this paper was
primarily to evaluate if visualization technology can help to
increase patient comprehension of their personal medication
schemes. However, a direct comparison with other systems
would have provided a stronger result. Finally, this paper
did not take privacy concerns into account that could
constraint the use of the system.
7. CONCLUSION AND FUTUREWORK
The PervasiveHealth domain has many stakeholders and
perspectives are varied [17]. This paper used the strength of
the HCI lens [17] and uses qualitative methods to determine
the perceived usefulness of our system. Our proof-of-concept
was designed following a user-centered, rapid-prototyping
methodology and evaluated during five iterations as was
observed earlier in Section 3. It was evaluated with in
total 40 participants; of which 25 in the final evaluation.
Moreover, the system was shown to 220 persons during the
department’s open house day.
Results are promising and clearly indicate that infor-
mation visualization techniques are an effective means to
explore and understand drug information. Moreover, our
results suggest there is actually a need for a visual system
to explore medication information. On top of that, our
proof-of-concept is able to show useful feedback and can
help both patients and GPs to explore adverse reactions,
schedules and recognize dangerous interactions. Although
our system was initially designed to be installed at the GP’s
office, results show that both GPs and patients think it
would be highly beneficial if patients were able to use the
system at home. In future work, we will focus on how to
integrate our visualization into a personal health record that
is linked to the GP’s EMR. This could enable patients to
explore medication questions individually before asking non-
resolved questions to their GP with the help of our system.
It is important our design is not just ported, but that specific
affordances of each medium are researched. For example, in
a personal health record medication system, the camera of
a smartphone could be used to recognize medication or to
scan barcodes.
We believe that with our iterative design process and final
evaluation, we were able to show the perceived usefulness.
This work will guide our future work, but it will hopefully
also guide other researchers’ future work, such as augmented
reality medication systems using, for instance, smartglasses
or IKEA’s kitchen concept 2025.
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